ESCALON MEDICAL CORP Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q2 2011 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Escalon Medical Corp quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q2 2011 to Q2 2024.
  • Escalon Medical Corp Deferred Tax Assets, Valuation Allowance for the quarter ending June 30, 2024 was $7.61M, a 0.71% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $7.61M +$53.4K +0.71% Jun 30, 2024 10-K 2024-09-30
Q2 2023 $7.55M -$95.1K -1.24% Jun 30, 2023 10-K 2024-09-30
Q2 2022 $7.65M +$106K +1.41% Jun 30, 2022 10-K 2023-10-13
Q2 2021 $7.54M -$66K -0.87% Jun 30, 2021 10-K 2022-09-28
Q2 2020 $7.61M -$10.4K -0.14% Jun 30, 2020 10-K 2021-09-27
Q2 2019 $7.62M +$56.9K +0.75% Jun 30, 2019 10-K 2020-09-28
Q2 2018 $7.56M -$4.5M -37.3% Jun 30, 2018 10-K 2019-09-27
Q2 2017 $12.1M +$148K +1.24% Jun 30, 2017 10-K 2018-09-28
Q2 2016 $11.9M +$284K +2.44% Jun 30, 2016 10-K 2017-09-28
Q2 2015 $11.6M +$215K +1.89% Jun 30, 2015 10-K 2016-10-12
Q2 2014 $11.4M -$233K -2% Jun 30, 2014 10-K/A 2015-09-29
Q2 2013 $11.6M -$717K -5.8% Jun 30, 2013 10-K 2014-09-26
Q2 2012 $12.4M +$518K +4.37% Jun 30, 2012 10-K 2013-09-20
Q2 2011 $11.8M Jun 30, 2011 10-K 2012-09-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.